How does the GHRH + GHRP synergy work on the somatotropic axis
PMC National Center for Biotechnology Information
The mechanism behind these hepatic benefits likely involves the medication's effects on weight reduction, enhanced insulin sensitivity, and reduced hepatic glucose production
Gene expression analysis revealed Clock expression in leukocytes decreased 1.8-fold, Cry2 expression doubled, and Csnk1e expression in lymphocytes decreased 2.1-foldall statistically significant changes indicating re-entrainment of disrupted circadian oscillations
Hepatic steatosis further disrupts insulin-mediated suppression of hepatic gluconeogenesis, a process that accounts for 90% of endogenous glucose production [13, 14]
Medical weight loss medications can be seen as a booster to help lose weight while practicing a healthy diet and moderate exercise